Clinical trial
Protein Biomarkers for Early Detection and Prognostication in Hepatocellular Carcinoma (HCC)
NCT00465842 is registered in ClinicalTrials.gov with Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Protein Biomarkers for Early Detection and Prognostication in Hepatocellular Carcinoma (HCC)
- Lead sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Phase
- Observational
- Overall status
- Terminated
- Start date
- June 20, 2006
- Completion date
- August 14, 2013
- Enrollment
- 211 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hepatitis, hepatocellular carcinoma, liver cirrhosis, normal volunteers